DESIGN THERAPEUTICS INC (DSGN) Stock Cash Flow
NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -47.78M | -66.86M | -63.31M | -35.53M | -8.28M | |||
| Depreciation Amortization | 584.00K | 537.00K | 410.00K | 130.00K | 10.00K | |||
| Change In Working Capital | -4.60M | 728.00K | 2.05M | 1.42M | -810.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 20.00K | |||
| Other non cash items | 5.75M | 7.04M | 9.53M | 4.61M | 420.00K | |||
| OPERATING CASH FLOW | -46.05M | -58.56M | -51.32M | -29.38M | -8.67M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -366.00K | -256.00K | -920.00K | -1.54M | -80.00K | |||
| Other Investing Activity | 48.05M | 52.79M | -220.07M | -52.11M | -33.49M | |||
| INVESTING CASH FLOW | 47.68M | 52.54M | -220.99M | -53.64M | -33.56M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -200.00K | |||
| Stock Issued/Repurchased | 754.00K | 724.00K | 660.00K | 379.21M | 44.73M | |||
| Other Financing Activity | N/A | 0.00 | -430.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 754.00K | 724.00K | 240.00K | 379.21M | 44.53M | |||
| CHANGE IN CASH | 2.39M | -5.30M | -272.07M | 296.19M | 2.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -46.05M | -58.56M | -51.32M | -29.38M | -8.67M | |||
| Capital Expenditure | -366.00K | -256.00K | -920.00K | -1.54M | -80.00K | |||
| FREE CASH FLOW | -46.41M | -58.82M | -52.24M | -30.92M | -8.75M | |||
All data in USD